News Releases
- March 4, 2010
Isotechnika Pharma receives National Research Council IRAP funding for NICAM program
EDMONTON, March 4 /CNW/ - Isotechnika Pharma Inc. (TSX: ISA) today announced that it has received funding approval from the National Research Council's Industrial Research Assistance Program (IRAP) for its ...
- March 2, 2010
European authorities accept voclosporin for regulatory review
Trades on Toronto Stock Exchange - (TSX: ISA) EDMONTON, March 2 /CNW/ - Isotechnika Pharma Inc. (TSX: ISA) today announced that the European Medicines Agency (EMA) has validated the ...
- February 18, 2010
Isotechnika Pharma announces sale of Isodiagnostika to Paladin Labs
Trades on Toronto Stock Exchange - (TSX: ISA) EDMONTON, Feb. 18 /CNW/ - Isotechnika Pharma Inc. (TSX: ISA) today announced that its wholly owned subsidiary, Isotechnika Labs, has amended its ...
- February 4, 2010
Isotechnika partner files for approval of voclosporin in US and Europe
Trades on Toronto Stock Exchange - (TSX: ISA) EDMONTON, Feb. 4 /CNW/ - Isotechnika Pharma Inc. (TSX: ISA) today announced that its partner, Lux Biosciences, Inc., has filed a New Drug ...
- November 11, 2009
Isotechnika Pharma reports third quarter 2009 financial results
EDMONTON, Nov. 11 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA) today announced its financial results for the third quarter ended September 30, 2009. ...
- October 29, 2009
EDMONTON, Oct. 29 /CNW/ - Isotechnika Pharma Inc. (TSX: ISA) today announced that it has developed a portfolio of non-immunosuppressive cyclosporine analogue molecules (NICAMs) with potent cyclophilin inhibition. ...
- October 27, 2009
Isotechnika Pharma Announces Voclosporin Presentations at American Academy of Ophthalmology
-- Partner Lux Biosciences Preparing to File for US and European Approvals -- EDMONTON, Oct. 27 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA) today ...
- August 13, 2009
Isotechnika Pharma appoints Dr. Jurgen Engel to Board of Directors
EDMONTON, Aug. 13 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA) today announced that it has appointed Dr. Jurgen Engel to its Board of Directors. ...
- August 6, 2009
Isotechnika Pharma reports second quarter 2009 financial results
EDMONTON, Aug. 6 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA) today announced its financial results for the second quarter ended June 30, 2009. ...
- July 6, 2009
Isotechnika Pharma presents at the Canadian Dermatology Association Conference
EDMONTON, AB, July 6 /CNW/ - Isotechnika Pharma Inc. (TSX:ISA), announced today that three posters were presented by Investigators, in the Phase 3 ...